Yükleniyor... / Loading...
This study examines, in a double-blind way, the effects of a dietary intervention with EPA (eicosapentaenoic acid) and lipoic acid in people with obesity. It included women aged 20-45 with regular menstrual cycles and a body mass index between 27.5 and 39.9. It was carried out as a study with no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Women * Ages between 20 and 45 years, and with regular menstrual cycles * Body Mass Index (BMI) between 27.5 and 39.9 kg/m2 * Weight unchanged (± 3 kg) for the last 3 months * All subjects should have an overall physical and psychological condition that the investigator believes is in accordance with the overall aim of the study. Exclusion Criteria: * Use of prescription medication * To suffer from any chronic metabolic or obesity related disease, hepatic or renal systemic disease: Hypertension, dislipidemia, type 1 or 2 diabetes, thyroid function disorders, cirrhosis, fatty liver, etc. * Food allergies or food intolerance expected to come up during the study * Special diets (Atkins, vegetarian, etc.) prior three months the start of the study. * Eating disorders * Surgically treated obesity * Pregnant or lactating women or planning to be pregnant in the next two months * Alcohol or drug abuse (based on clinical parameters)